Preferential cytotoxicity for multidrug-resistant K562 cells using the combination of a photosensitizer and a cyanine dye

Journal of Photochemistry and Photobiology B: Biology

Volumn 54, Issue 2-3, 2000, Pages 136-144

  Kanofsky, Jeffrey R ^a,b   Sima, Paul D ^c  

^a Medical Service   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c Research Service   (United States)

Author keywords

1,1',3,3,3',3' Hexamethylindodicarbocyanine iodide; Cis di (4 sulfonatophenyl) diphenylporphine; Multidrug resistance; Photodynamic therapy; Singlet oxygen

Indexed keywords

CYANINE DYE; CYTOTOXIC AGENT; DI(4 SULFONATOPHENYL)DIPHENYLPORPHINE; GLYCOPROTEIN P; PHOTOSENSITIZING AGENT; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL LEVEL; CELL PROTECTION; CELL STRAIN K 562; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MULTIDRUG RESISTANCE; PHENOTYPE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

CELL MEMBRANE; COLORING AGENTS; CYANIDES; DRUG RESISTANCE; HUMANS; K562 CELLS; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 0034005790     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(00)00008-7     Document Type: Article

References (40)

1. Beck W.T. The cell biology of multiple drug resistance. Biochem. Pharmacol. 36:1987;2879-2887.
2. Bradley G., Juranka P.F., Ling V. Mechanism of multidrug resistance. Biochim. Biophys. Acta. 948:1988;87-128.
3. Stein W.D. Kinetics of the multidrug transporter (p-glycoprotein) and its reversal. Physiol. Rev. 77:1997;545-590.
4. Bradshaw D.M., Arceci R.J. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J. Clin. Oncol. 16:1998;3674-3690.
5. Senior A.E., Al-Shawi M.K., Urbatsch I.L. The catalytic cycle of p-glycoprotein. FEBS Lett. 377:1995;285-289.
6. Wadkins R.M., Roepe P.D. Biophysical aspects of p-glycoprotein-mediated multidrug resistance. Int. Rev. Cytology. 171:1997;121-165.
7. i and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J. Gen. Physiol. 108:1996;295-313.
8. Hasmann M., Valet G.K., Tapiero H., Trevorrow K., Lampidis T. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry. Biochem. Pharmacol. 38:1989;305-312.
9. Wadkins R.M., Houghton P.J. Kinetics of transport of dialkyloxacarbocyanines in multidrug-resistant cell lines overexpressing p-glycoprotein: interrelationship of dye alkyl chain length, cellular flux, and drug resistance. Biochemistry. 34:1995;3858-3872.
10. Kühnel J.M., Perrot J.Y., Faussat A.M., Marie J.P., Schwaller M.A. Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia. 11:1997;1147-1155.
11. Deadwyler G., Sima P.D., Fu Y., Kanofsky J.R. Singlet oxygen-mediated inactivation of acetocholinesterase: a comparison of purified enzyme in solution and enzyme bound to K562 leukemia cells. Photochem. Photobiol. 65:1997;884-894.
12. Kessel D. Exploring multidrug resistance using rhodamine 123. Cancer Commun. 1:1989;145-149.
13. Demant E.J.F., Friche E. Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding. Biochem. Pharmacol. 56:1998;1209-1217.
14. Netzel T.L., Nafisi K., Zhao M., Lenhard J.R., Johnson I. Base-content dependence of emission enhancements, quantum yields, and lifetimes for cyanine dyes bound to double-strand DNA: photophysical properties of monomeric and bichromophoric DNA stains. J. Phys. Chem. 99:1995;17936-17947.
15. Becker B., Clapper J., Harkins K.R., Olson J.A. In situ screening assay for cell viability using a dimeric cyanine nucleic acid stain. Anal. Biochem. 221:1994;78-84.
16. Kanofsky J.R. Quenching of singlet oxygen by human plasma. Photochem. Photobiol. 51:1990;299-303.
17. Baker A., Kanofsky J.R. Quenching of singlet oxygen by biomolecules from L1210 leukemia cells. Photochem. Photobiol. 55:1992;523-528.
18. - cases. Blood. 86:1995;2329-2342.
19. Moan J., Christensen T. Photodynamic inactivation of cancer cells in vitro. Effect of irradiation temperature and dose fractionation. Cancer Lett. 6:1979;331-335.
20. Kessel D., Erickson C. Porphyrin photosensitization of multi-drug resistant cell types. Photochem. Photobiol. 55:1992;397-399.
21. Tempête C., Giannotti C., Werner G.H. Identical photosensitizing activities of a sulfonated aluminum phthalocyanine on human erythroleukemia cell lines susceptible or resistant to the cytotoxic activity of doxorubicin. J. Photochem. Photobiol., B: Biol. 14:1992;201-205.
22. P. Sonneveld, H.M. Lokhurst, P. Vossebeld, Drug resistance in multiple myeloma, Semin. Hematol. 34, Suppl. 5 (1997) 34-39.
23. Luna M.C., Gomer C.J. Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy. Cancer Res. 51:1991;4243-4249.
24. Sharkey S.M., Wilson B.C., Moorehead R., Singh G. Mitochondrial alterations in photodynamic therapy-resistant cells. Cancer Res. 53:1993;4994-4999.
25. Klein E., Ben-Bassat H., Neumann H., Ralph P., Zeuthen J., Polliac A., Vánky F. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int. J. Cancer. 18:1976;421-431.
26. Egorov S.Y., Kamalov V.F., Koroteev N.I., Krasnovsky Jr A.A., Toleutaev B.N., Sinukov S.V. Rise and decay kinetics of photosensitized singlet oxygen luminescence in water. Measurements with nanosecond time-correlated single photon counting technique. Chem. Phys. Lett. 163:1989;421-424.
27. Matheson I.B.C., Etheridge R.D., Kratowich N.R., Lee J. The quenching of singlet oxygen by amino acids and proteins. Photochem. Photobiol. 21:1975;165-171.
28. Moan J., Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53:1991;549-553.
29. Anderson W.M., Chambers B.B., Wood J.M., Benninger L. Inhibitory effects of two structurally related carbocyanine laser dyes on the activity of bovine heart mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase. Biochem. Pharmacol. 41:1991;677-684.
30. Byers G.W., Gross S., Henrichs P.M. Direct and sensitized photooxidation of cyanine dyes. Photochem. Photobiol. 23:1976;37-43.
31. Carre C., Reichardt C., Lougnot D.J. Étude physicochimique d'une série de cyanines: partie VII: rendement en état triplet et photosensibilisation de l'oxygène singulet. J. Chim. Phys. Phys.-Chim. Biol. 84:1987;577-585.
32. Harriman A., Luengo G., Gulliya K.S. In vitro photodynamic activity of kryptocyanine. Photochem. Photobiol. 52:1990;735-740.
33. Nakagawa Y., Hori H., Yamamoto I., Terada H. Characteristic bleaching profiles of cyanine dyes depending on active oxygen species in the controlled Fenton reaction. Biol. Pharm. Bull. 16:1993;1061-1064.
34. Valdes-Aguilera O., Ara G., Kochevar I.E. Phototoxicity mechanism of a kryptocyanine dye in human red cell membranes and isolated murine mitochondria. Cancer Res. 48:1988;6794-6798.
35. Lee C., Wu S.S., Chen L.B. Photosensitization by 3,3′-dihexyloxacarbocyanine iodide: specific disruption of microtubules and inactivation of organelle motility. Cancer Res. 55:1995;2063-2069.
36. B.I. Sikic, Pharmacologic approaches to reversing multidrug resistance, Semin. Hematol. 34, Suppl. 5 (1997) 40-47.
37. A.F. List, K.J. Kopecky, C.L. Willman, C. Spier, R. Dorr, L. Flaherty, H. Hynes, F. Appelbaum, Benefit of cyclosporine (CsA) modulation of anthracycline resistance in high-risk AML: a Southwest Oncology Group (SWOG) study, Blood 92, Suppl. 1 (1998) 312a.
38. Kühl J.-S., Sikic B.I., Blume K.G., Chao N.J. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model. Exp. Hematol. 20:1992;1048-1054.
39. Wagner J.R., Motchnik P.A., Stocker R., Sies H., Ames B.N. The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. J. Biol. Chem. 268:1993;18502-18506.
40. Nagano T., Tanaka T., Mizuki H., Hirobe M. Toxicity of singlet oxygen generated thermolytically in Escherichia coli. Chem. Pharm. Bull. 42:1994;883-887.